Amazon.com, Inc.

• AMZN Stock Price 24h change: +0.44%. From 246.29 USD to 247.38 USD.
• Technical analysis indicates a strong "bullish consolidation": the price remains above the 20-day and 50-day moving averages, with key support at $240 and resistance at $248. Analysts note a classic bull market structure as the stock approaches new 52-week highs following a period of underperformance in 2025.
• Amazon Pharmacy expanded its services by offering the Wegovy weight-loss pill with insurance and cash-pay options, potentially boosting recurring high-margin revenue.
• The company launched "Alexa+ Web," a desktop-based AI assistant available for free to Prime members, a strategic move aimed at deepening customer retention and challenging paid AI rivals.
• AWS revenue growth has accelerated to 20% YoY, signaling that capacity constraints are easing and the "Return on AI" thesis is beginning to manifest in cloud earnings.
• The S&P 500 and Dow Jones reached new all-time highs in early January, driven by a rotation into Consumer Discretionary and Value sectors, reflecting a broadening bull market.
• Technology shares experienced profit-taking recently due to elevated Treasury yields and caution ahead of key economic data, despite continued optimism around generative AI adoption.

• AMZN Stock Price 24h change: +0.44%. From 246.29 USD to 247.38 USD.
The stock extended its gains as investors maintained a bullish outlook ahead of late-January earnings, supported by strong AWS performance and recent analyst upgrades from Wolfe Research and Jefferies.• From a technical perspective, AMZN is in a "strong bullish re-acceleration": the stock has surged roughly 9% over the last three sessions, convincingly reclaiming its 20-day (230.90) and 50-day (232.96) moving averages. While the RSI (69.1) is approaching overbought territory, the MACD bullish crossover and price action near the 52-week high suggest strong momentum.• Amazon Pharmacy expanded its services on January 9 by offering insurance and cash-pay options for the new Wegovy weight-loss pill, further growing its healthcare footprint.
• Reports emerged on January 7 that Amazon will initiate a significant restructuring starting January 26, 2026, potentially impacting up to 30,000 corporate and middle-management roles to drive AI efficiency.
• Analyst sentiment remains high as Jefferies raised its price target to $300, citing AWS re-acceleration and margin expansion as primary long-term growth drivers.• The Consumer Discretionary sector (XLY) rose 1.7% on January 8, outperforming the broader market as investors rotated into cyclical names amid cooling AI fever in pure-play tech.
• Global electronics manufacturers warned on January 9 that surging demand for AI-specific memory chips will likely trigger a 5-20% price hike for consumer hardware through 2026.